We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $9.31B
1-Year Est. Return 73.66%
This Fund
S&P 500
This Quarter Est. Return
+84.9%
1 Year Est. Return
+73.66%
3 Year Est. Return
+373.34%
5 Year Est. Return
10 Year Est. Return
AUM
$9.31B
AUM Growth
+$2.53B
Cap. Flow
+$1.27B
Cap. Flow %
13.64%
Top 10 Hldgs %
53.63%
Holding
384
New
125
Increased
85
Reduced
84
Closed
64

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$566M
2
SPCX
SpaceX
SPCX
+$254M
3
AMD icon
Advanced Micro Devices
AMD
+$149M
4
NOW icon
ServiceNow
NOW
+$121M
5
AVGO icon
Broadcom
AVGO
+$75.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.34%
2 Technology 35%
3 Financials 5.44%
4 Industrials 4.27%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBTG icon
151
American Express Global Business Travel
GBTG
$4.95B
$4.08M 0.04%
+434,666
New +$3.52M
ONTO icon
152
Onto Innovation
ONTO
$13.2B
$3.92M 0.04%
+10,345
New +$2.93M
PCT icon
153
PureCycle Technologies
PCT
$1.28B
$3.89M 0.04%
479,800
-299,117
-38% -$2.68M
DRAM
154
Roundhill Memory ETF
DRAM
$28B
$3.87M 0.04%
+52,362
New +$2.73M
QBTS icon
155
CALL
D-Wave Quantum Inc
QBTS
$6.18B
$3.84M 0.04%
160,000
-480,000
-75% -$10.5M
DMII
156
Drugs Made In America Acquisition II Corp
DMII
$648M
$3.65M 0.04%
+363,100
New +$3.64M
DUOT icon
157
Duos Technologies
DUOT
$276M
$3.59M 0.04%
+300,000
New +$3.02M
IMSRW
158
Terrestrial Energy Warrant
IMSRW
$23.9M
$3.53M 0.04%
1,082,851
-200
-0% -$678
RNA
159
Atrium Therapeutics
RNA
$243M
$3.46M 0.04%
256,917
+21,280
+9% +$278K
SWKS icon
160
Skyworks Solutions
SWKS
$11.1B
$3.24M 0.03%
+47,760
New +$3.25M
XOVR
161
PUT
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.76B
$3.16M 0.03%
+150,000
New +$2.86M
CAVA icon
162
CAVA Group
CAVA
$7.1B
$3.08M 0.03%
39,214
KMB icon
163
Kimberly-Clark
KMB
$34.9B
$2.91M 0.03%
+26,472
New +$2.62M
BULL
164
Webull Corp
BULL
$5.26B
$2.73M 0.03%
418,208
-116,400
-22% -$754K
CCL icon
165
Carnival Corporation Ltd
CCL
$32.2B
$2.71M 0.03%
+95,019
New +$2.6M
SOUN icon
166
SoundHound AI
SOUN
$2.99B
$2.67M 0.03%
413,334
-184,543
-31% -$1.43M
INSM icon
167
Insmed
INSM
$27.6B
$2.67M 0.03%
25,000
+14,000
+127% +$1.7M
INSM icon
168
PUT
Insmed
INSM
$27.6B
$2.67M 0.03%
+25,000
New +$3.03M
AAL icon
169
American Airlines Group
AAL
$8.69B
$2.66M 0.03%
147,450
-51,200
-26% -$685K
VT icon
170
Vanguard Total World Stock ETF
VT
$81.5B
$2.66M 0.03%
16,960
+5,650
+50% +$862K
WYFI
171
WhiteFiber Inc
WYFI
$759M
$2.65M 0.03%
+68,279
New +$1.65M
LPRO
172
DELISTED
Open Lending Corp
LPRO
$2.56M 0.03%
+824,173
New +$1.68M
OSCR icon
173
Oscar Health
OSCR
$9.95B
$2.5M 0.03%
87,652
-73,676
-46% -$1.59M
CABA icon
174
Cabaletta Bio
CABA
$588M
$2.49M 0.03%
800,001
+35,001
+5% +$115K
LMND icon
175
Lemonade
LMND
$4.13B
$2.38M 0.03%
36,664
-3,459
-9% -$202K

Similar funds

Cantor Fitzgerald's Q2 2026 Portfolio in Review

As of Q2 2026, Cantor Fitzgerald held 384 positions worth $9.31B, up 37% from $6.78B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Cantor Fitzgerald deployed $1.27B of net new capital in Q2 2026, opening 125 new positions and adding to 85 existing holdings. Its largest new stake was SpaceX: 1,496,980 shares worth $256M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 63% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Strategy Inc, an estimated $136M trimmed.

  • Cantor Fitzgerald's largest Q2 2026 buy was SpaceX: 1,496,980 shares worth $256M.
  • Cantor Fitzgerald added most to Marvell Technology in Q2 2026, an estimated $566M increase.
  • Cantor Fitzgerald's biggest Q2 2026 reduction was Strategy Inc, cutting an estimated $136M.
  • Cantor Fitzgerald fully exited Shell in Q2 2026, selling an estimated $39.8M.
  • Cantor Fitzgerald's ten largest holdings make up 54% of its $9.31B portfolio in Q2 2026.
  • Cantor Fitzgerald opened 125 new positions and closed 64 in Q2 2026.
  • Cantor Fitzgerald's portfolio value rose 37% quarter-over-quarter to $9.31B.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.